LivingGLP1
Study S000028

A Real-World Study on Changes in Sleep Apnea Among Patients With Type 2 Diabetes/Obesity and Comorbid OSA After Short-Term Treatment With Semaglutide

ClinicalTrials.gov record

Registration

Registration
NCT07281196
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
15
Start
2025-01-01
Primary completion
2025-12-31
Lead sponsor
Shanghai Fengxian District Central Hospital
Conditions
Sleep Apnea Syndrome (OSAS)
Interventions
DRUG:Semaglutide Subcutaneous Injection
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Changes in Apnea-Hypopea Index (AHI) [Baseline and 1 week]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.